858PSacituzumab govitecan (IMMU-132) for patients with pretreated metastatic urothelial uancer (UC): interim results
Tagawa, S.T., Faltas, B., Lam, E., Saylor, P., Bardia, A., Hajdenberg, J., Morgans, A.K., Lim, E., Kalinsky, K., Petrylak, D.P., Guarino, M., Galsky, M.D., Maliakal, P., Mudenda, B., Sharkey, R., WegeVolume:
28
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdx371.012
Date:
September, 2017
File:
PDF, 95 KB
english, 2017
File converter
More search results
More benefits 
